SV2002000418A - INHIBITOR OF THE PARTNER-HYDROGEN EXCHANGER OF TYPE 1 REF. PC1086AADO / BB - Google Patents

INHIBITOR OF THE PARTNER-HYDROGEN EXCHANGER OF TYPE 1 REF. PC1086AADO / BB

Info

Publication number
SV2002000418A
SV2002000418A SV2001000418A SV2001000418A SV2002000418A SV 2002000418 A SV2002000418 A SV 2002000418A SV 2001000418 A SV2001000418 A SV 2001000418A SV 2001000418 A SV2001000418 A SV 2001000418A SV 2002000418 A SV2002000418 A SV 2002000418A
Authority
SV
El Salvador
Prior art keywords
inhibitor
pc1086aado
ref
partner
type
Prior art date
Application number
SV2001000418A
Other languages
Spanish (es)
Inventor
Weichao George Chen
Eric David Cox
Perez Angel Guzman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV2002000418A publication Critical patent/SV2002000418A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

UN INHIBIDOR DE NHE-1, METODOS PARA UTILIZAR EL INHIBIDOR DE NHE-1 Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL INHIBIDOR DE NHE-1. EL INHIBIDOR DE NHE-1 ES UTIL PARA LA REDUCCION DE LAS LESIONES TISULARES RESULTANTES DE LA ISQUEMIA DE LOS TEJIDOS.AN NHE-1 INHIBITOR, METHODS FOR USING THE NHE-1 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE NHE-1 INHIBITOR. THE NHE-1 INHIBITOR IS USEFUL FOR THE REDUCTION OF THE TISSULAR INJURIES RESULTING FROM THE TISSUE ISCHEMIA.

SV2001000418A 2000-04-28 2001-04-27 INHIBITOR OF THE PARTNER-HYDROGEN EXCHANGER OF TYPE 1 REF. PC1086AADO / BB SV2002000418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
SV2002000418A true SV2002000418A (en) 2002-07-03

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000418A SV2002000418A (en) 2000-04-28 2001-04-27 INHIBITOR OF THE PARTNER-HYDROGEN EXCHANGER OF TYPE 1 REF. PC1086AADO / BB

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060892A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
CA2469305A1 (en) * 2001-12-19 2003-06-26 Frank Robert Busch Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
CA2483927A1 (en) * 2002-05-02 2003-11-13 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
EP1596860A4 (en) * 2003-02-14 2009-05-27 Smithkline Beecham Corp Novel compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
UY26680A1 (en) 2001-12-28
OA12256A (en) 2003-11-06
CR6797A (en) 2004-05-17
MXPA02010600A (en) 2003-03-10
IS6588A (en) 2002-10-21
TNSN01065A1 (en) 2005-11-10
DZ3310A1 (en) 2001-11-07
IS6567A (en) 2002-09-24
JP2003531900A (en) 2003-10-28
CO5221125A1 (en) 2002-11-28
PL357765A1 (en) 2004-07-26
IL152075A0 (en) 2003-05-29
TR200202439T2 (en) 2003-02-21
EP1276737A1 (en) 2003-01-22
NO20025132D0 (en) 2002-10-25
PE20011270A1 (en) 2001-12-12
MA26897A1 (en) 2004-12-20
YU79602A (en) 2006-05-25
NZ521348A (en) 2004-09-24
UA73348C2 (en) 2005-07-15
NO20025132L (en) 2002-12-12
CN1426404A (en) 2003-06-25
KR20020093079A (en) 2002-12-12
AU2001235896A1 (en) 2001-11-12
AP2002002651A0 (en) 2002-12-31
GT200100064A (en) 2002-03-22
HN2001000042A (en) 2001-07-09
EE200200615A (en) 2004-04-15
HUP0300651A2 (en) 2003-07-28
CA2407535A1 (en) 2001-11-08
HRP20020851A2 (en) 2005-02-28
BG107139A (en) 2003-07-31
ZA200208605B (en) 2003-10-24
EA200201023A1 (en) 2003-02-27
WO2001083470A1 (en) 2001-11-08
CN1225466C (en) 2005-11-02
BR0110268A (en) 2003-12-30
SK14872002A3 (en) 2004-03-02
PA8513301A1 (en) 2003-09-05
EA004882B1 (en) 2004-08-26
AR028375A1 (en) 2003-05-07
MY133842A (en) 2007-11-30
CZ20023408A3 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
GT199900022A (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
AR019503A1 (en) USE OF SUBSTITUTED DERIVATIVES IN 3 OF THE STYLBENE AS DEODORANT ACTIVE AGENTS IN COSMETIC COMPOSITIONS
ES2157027T3 (en) OXAZOLIDINONES REPLACED AND ITS USE AS ANTIBACTERIAL PHARMACOS.
BR9913745A (en) Pyridine ketones useful as herbicides
BR0317822A (en) Fluorochemical composition
ES2145638T3 (en) NEW AZOIC COMPOUNDS, USE FOR STAINING, CONTAINING COMPOSITIONS AND STAINING PROCEDURES.
SV2002000520A (en) DERIVATIVES OF PIRAZOL REF. PCS10927AAJR / BB
BR0215405A (en) Compositions and processes of use of collajolie
ECSP055747A (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS
ES2146552B1 (en) INHIBITING PEPTIDES OF TGF / 31
DK0988292T3 (en) Piperazine derivatives and their use as anti-inflammatory agents
BR9811948A (en) Growth hormone secretors
ATE416157T1 (en) INHIBITORS OF INTEGRIN ALPHA-V-BETA-6
AR016981A2 (en) SYNTHETIC POLYPEPTIDES
PA8586801A1 (en) HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
AR015945A1 (en) AUTOFOBIC HAIR SPRAY COMPOSITIONS
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
UY27203A1 (en) USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION
AR044453A1 (en) METOXI-PIRAZIN-TIENIL SULFONAMIDE DERIVATIVES
SV2002000418A (en) INHIBITOR OF THE PARTNER-HYDROGEN EXCHANGER OF TYPE 1 REF. PC1086AADO / BB
SE9801494D0 (en) Novel use
AR030537A1 (en) ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS
BR9916807A (en) 5ht1 antagonists for antidepressant therapy

Legal Events

Date Code Title Description
FD Lapse